Clinical Characteristics of Influenza Pneumonia in Patients with Lung Adenocarcinoma Receiving Immunotherapy
Viral Immunology · 2025
DOI: 10.1177/08828245251362175 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viral Immunology, 2025. Verfasst von Weiyi Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: North China University of Science and Technology, Tangshan, China. Hauptthemen laut MEDLINE: Influenza, Human, Adenocarcinoma of Lung, Lung Neoplasms, Immunotherapy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 40 Literaturangaben.
Abstract (Originalsprache)
The objective of this study is to examine the general characteristics, clinical manifestations, laboratory findings, and imaging features of patients with lung adenocarcinoma who develop influenza pneumonia while undergoing immunotherapy. A retrospective analysis was conducted on the clinical data of 48 patients with lung adenocarcinoma and pulmonary infections who received immunotherapy as a stand-alone treatment between September 2022 and September 2024 at the Affiliated Hospital of North China University of Science and Technology. Clinical characteristics of patients with concurrent influenza pneumonia were assessed. When compared with the non-influenza pneumonia group, patients in the influenza pneumonia group demonstrated significantly more severe systemic symptoms, elevated urea nitrogen levels, reduced platelet counts, decreased serum albumin levels, lower Prognostic Nutritional Index values, and higher prevalence of bilateral and multilobed lung involvement. Chest imaging frequently revealed ground glass opacities, reticular patterns, and the “crazy paving” sign. Additionally, this group exhibited higher CURB-65 scores and an increased need for intensive care unit admission, with all comparisons yielding p values
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- North China University of Science and Technology, Tangshan, China.
- Respiratory Diagnosis and Treatment Center, Affiliated Hospital of North China University of Science and Technology, Tangshan, China.
- Platform for Prevention and Control of Respiratory Diseases and Health, Affiliated Hospital of North China University of Science and Technology, Tangshan, China.
- The Third Department of Respiration and Critical Illness, Affiliated Hospital of North China University of Science and Technology, Tangshan, China.
ORCID-Profile: Yan Huang
Zitieren
APA
Li, W., Zhang, D., Feng, H., Jin, J., Li, C., Li, C., Zhang, L., & Huang, Y. (2025). Clinical Characteristics of Influenza Pneumonia in Patients with Lung Adenocarcinoma Receiving Immunotherapy. Viral Immunology. https://doi.org/10.1177/08828245251362175
Vancouver
Li W, Zhang D, Feng H, Jin J, Li C, Li C, et al. Clinical Characteristics of Influenza Pneumonia in Patients with Lung Adenocarcinoma Receiving Immunotherapy. Viral Immunology. 2025. doi:10.1177/08828245251362175
BibTeX
@article{Li2025,
author = {Li, Weiyi and Zhang, Dan and Feng, Haitong and Jin, Jingjing and Li, Caihong and Li, Chenguang and Zhang, Lijing and Huang, Yan},
title = {Clinical Characteristics of Influenza Pneumonia in Patients with Lung Adenocarcinoma Receiving Immunotherapy},
journal = {Viral Immunology},
year = {2025},
doi = {10.1177/08828245251362175}
}
EUVIMED